Project Grant R03LM014974
- This federal Project Grant award of $524,400.00 was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding supports research at the Scripps Research Institute in La Jolla, CA to develop novel chemical transformations and catalysts that enable the efficient synthesis of structurally complex small molecules for drug discovery. The research aims to address challenges in organic synthesis by...
- The Scripps Research Institute was awarded a $404,450 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The grant, awarded on August 11, 2025, supports a two-year program to train a cohort of elite Scripps Research students in specialized translational chemical biology skills. The program aims to equip these students with advanced chemical biology and drug discovery capabilities to transition...
- This Project Grant award of $288,107 from the National Institute on Drug Abuse (NIDA), which falls under CFDA 93.279 Drug Use and Addiction Research Programs, aims to develop a new generation of leaders in addiction research. The key products or services to be provided under this grant include: Establishing a predoctoral training program at the Scripps Research Institute to equip young scientists with technical skills and expertise in transdisciplinary "team science" needed to...
- This $417,984 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research on pharmacological modulation of regulatory T cells. The project aims to: Identify the target and mechanism of action for a novel small molecule compound (A205804) that induces functional regulatory T cell differentiation in human and mouse cells. Optimize the pharmacokinetic properties of...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), awarded a $608,652 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to the Scripps Research Institute. The purpose of this 5-year award, with a start date of September 1, 2025, is to conduct data mining and functional validation of the Systematic Characterization of Retroviral Conditions for Health (SCORCH) datasets. The research aims to elucidate the key pathogenic...
- This federal Project Grant award for $874,000.00, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research on enantioselective and site-selective C-H activation reactions. The key objectives are to develop next-generation ligands capable of enantio- and site-selective C(SP3)-H activation of aliphatic carboxylic acid substrates, as well as to achieve enantio- and site-selective ring...
- The U.S. Department of Health and Human Services National Institutes of Health (NIH) awarded a $2,804,900 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Scripps Research Institute. The grant, awarded on August 15, 2025, will support the development of a "Somatosensory Atlas for Interoception" by August 31, 2030. The project aims to use innovative tools to label, visualize, and isolate sensory neurons that innervate internal organs and convey information...
- The Scripps Research Institute was awarded a $313,482 Project Grant from the National Science Foundation under the Biological Sciences federal grant program (CFDA 47.074) for the period of March 15, 2021 through August 31, 2022. The grant funding supports research titled "Bidirectional Transport of Lysosome Related Organelles During Synapse Maintenance and Plasticity." In line with the program's goals of advancing the biological sciences and strengthening the national scientific...
- The Scripps Research Institute received a $582,422 Project Grant from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), to accelerate discovery by merging kinetics with data science methods in catalytic organic reactions. The project aims to advance the Blackmond Laboratory's pioneering work in kinetic-assisted mechanistic analysis of organic catalytic reactions, leveraging reaction progress kinetic analysis...
- The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded $852,121.24 to The Scripps Research Institute-Florida under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period of July 22, 2021 through October 31, 2021. The project aims to identify host factors that regulate HIV latency and reactivation in order to develop strategies for durable HIV silencing. The grantee will define the roles of three identified host factors, P32,...
The Scripps Research Institute was awarded a $276,000 Project Grant from the National Institutes of Health (NIH) Trans-NIH Research Support program (CFDA 93.310) to build a distributed ecosystem of biomedical Application Programming Interfaces (APIs) for promoting Findable, Accessible, Interoperable, and Reusable (FAIR) data sharing and knowledge integration in biomedical research. The project will create a framework for API creation, an API registry for management and discovery, and a semantic annotation and integration framework to enable cross-API interoperability. This distributed API ecosystem is intended to improve the efficiency of making biomedical data and knowledge resources more accessible and reusable, ultimately advancing scientific discovery and understanding across multiple biomedical research domains. The award period is from September 1, 2025 to August 31, 2027.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $276.0k | 8/25/25 |